SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-006944
Filing Date
2023-11-09
Accepted
2023-11-09 14:41:46
Documents
46
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20230930_10q.htm   iXBRL 10-Q 682772
2 EXHIBIT 31.1 ex_587299.htm EX-31.1 11178
3 EXHIBIT 31.2 ex_587300.htm EX-31.2 10483
4 EXHIBIT 32.1 ex_587301.htm EX-32.1 5349
  Complete submission text file 0001171843-23-006944.txt   3176125

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20230930.xsd EX-101.SCH 27304
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20230930_def.xml EX-101.DEF 216009
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20230930_lab.xml EX-101.LAB 181117
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20230930_pre.xml EX-101.PRE 234356
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20230930_cal.xml EX-101.CAL 28912
40 EXTRACTED XBRL INSTANCE DOCUMENT xbit20230930_10q_htm.xml XML 322950
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 231391832
SIC: 2834 Pharmaceutical Preparations